Nutra Pharma Announces Nyloxin Acceptance by Chinese Medical Authority - CPAM
April 30, 2015 Nutra Pharma Has Announced That They Have Received Notification of the Acceptance of Nyloxin(R) by the China International Exchange and Promotive Association for Medical and Healthcare (CPAM) CORAL SPRINGS, FL--(Marketwired - Apr 30, 2015) - Nutra Pharma Corporation (OTC: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they ha
Nutra Pharma Announces Nyloxin Distribution Plans for China
April 22, 2015 Nutra Pharma Has Announced That They Have Engaged the Vancouver Commodities Group to Begin the Process of Distributing Nyloxin(R) in the People's Republic of China CORAL SPRINGS, FL--(Marketwired - Apr 22, 2015) - Nutra Pharma Corporation (OTC: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they have engaged the Vancouver Com
Nutra Pharma Provides Updates on Marketing and Distribution of Nyloxin to India
April 15, 2015 Nutra Pharma Is Providing an Update on the Company's Efforts to Market and Distribute Their Over-the-Counter (OTC) Pain Reliever, Nyloxin(R) in India CORAL SPRINGS, FL--(Marketwired - Apr 15, 2015) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is providing an update regarding their plan to market their over-the-counter (OTC) pain reliever, Nyloxin® throug